P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

• Rafat Abonour,
• Robert Rifkin,
• Sikander Ailawadhi,
• Hans C. Lee,
• Christina Gasparetto,
• Lynne Wagner,
• Brian Durie,
• James Hardin,
• Howard Terebelo,
• Mohit Narang,
• Kathleen Toomey,
• Yuexin Tang,
• Sujith Dhanasiri,
• Jasmeet Anand,
• Edward Yu,
• Thomas Marshall,
• Liang Liu,
• Sundar Jagannath

Affiliations

Rafat Abonour

1 Indiana University Health Simon Cancer Center, Indianapolis, IN, United States

Robert Rifkin

2 Rocky Mountain Cancer Center, Denver, CO, United States

Sikander Ailawadhi

3 Mayo Clinic, Jacksonville, FL, United States

Hans C. Lee

4 The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Christina Gasparetto

5 Duke University School of Medicine, Durham, NC, United States

Lynne Wagner

6 Wake Forest University School of Medicine, Winston-Salem, NC, United States

Brian Durie

7 Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, United States

James Hardin

8 University of South Carolina Arnold School of Public Health, Columbia, SC, United States

Howard Terebelo

9 Ascension of Providence Hospital, Southfield, MI, United States

Mohit Narang

10 Maryland Oncology Hematology, Columbia, MD, United States

Kathleen Toomey

11 The Steeplechase Cancer Center, Somerville, NJ, United States

Yuexin Tang

12 Bristol Myers Squibb, Princeton, NJ, United States

Sujith Dhanasiri

13 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland

Jasmeet Anand

12 Bristol Myers Squibb, Princeton, NJ, United States

Edward Yu

12 Bristol Myers Squibb, Princeton, NJ, United States

Thomas Marshall

12 Bristol Myers Squibb, Princeton, NJ, United States

Liang Liu

12 Bristol Myers Squibb, Princeton, NJ, United States

Sundar Jagannath

14 Icahn School of Medicine at Mount Sinai, New York, NY, United States